Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 60.0M | 55.7M | 47.7M | 54.8M |
Cost of revenue | 27.5M | 27.4M | 22.5M | 31.5M |
Gross profit | 32.5M | 28.3M | 25.2M | 23.3M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 8.5M | 8.6M | 12.0M | 6.7M |
Other operating expenses | — | — | — | — |
Operating income | 24.0M | 19.7M | 13.3M | 16.6M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 85K | 94K | 102K | 104K |
Other income expense | — | — | — | — |
Pretax income | 24.5M | 20.2M | 14.0M | 16.6M |
Tax provision | 6.6M | 5.2M | 5.3M | 4.7M |
Net income | 17.9M | 15.0M | 8.8M | 11.9M |
Basic EPS | 0.0 | 0.0 | 0.0 | 0.0 |
Diluted EPS | 0.0 | 0.0 | 0.0 | 0.0 |
Basic average shares | 600M | 600M | 564.1M | 600M |
Diluted average shares | 600M | 600M | 564.1M | 600M |
EBITDA | 25.7M | 21.5M | 14.1M | 17.8M |
Net income from continuing op. | 24.5M | 20.2M | — | 16.6M |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |